Table 6 Clinical phenotypes of FH patients
FH patients (n = 19) | Non-FH patients (n = 206) | P value | |
|---|---|---|---|
Male, n(%) | 17 (89.5) | 171 (83.0) | 0.467 |
BMI (kg/m2) | 27.82 ± 5.28 | 26.60 ± 3.30 | 0.334 |
Age at MI onset (years) | 46.68 ± 7.97 | 50.43 ± 7.91 | 0.050 |
Family history of PCHD, n (%) | 11 (57.9) | 38 (18.4) | < 0.001 |
eGFR (ml/min/1.73m2) | 93.95 (76.40, 101.71) | 97.37 (84.17, 104.48) | 0.435 |
LDL-C (mmol/L) | 4.93 (4.80, 6.37) | 3.58 (2.95, 4.21) | < 0.001 |
LVEF (%) | 61.31 ± 12.22 | 60.90 ± 10.08 | 0.869 |
Gensini scores | 62 (48, 92) | 53.5 (32, 77.25) | 0.087 |
Tendon xanthoma/corneal arcus n(%) | 0 (0) | 0 (0) | 1.000 |
Multivessel lesion, n(%) | 15 (78.9) | 161 (78.2) | 0.936 |
Smoking, n (%) | 17 (89.5) | 136 (66.0) | 0.036 |
Hyperlipemia, n (%) | 11 (57.9) | 64 (31.1) | 0.018 |
Hypertension, n (%) | 4 (21.1) | 112 (54.4) | 0.005 |
Diabetes, n (%) | 7 (36.8) | 76 (36.9) | 0.996 |